The current institutional shareholding score of Barinthus Biotherapeutics PLC is 3.00, ranking 192 out of 387 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 40.87%, representing a quarter-over-quarter decrease of 10.63%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.37% of shares outstanding, with 0.08% increase in holdings.